0001415889-22-004958.txt : 20220513 0001415889-22-004958.hdr.sgml : 20220513 20220513164208 ACCESSION NUMBER: 0001415889-22-004958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220511 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Payson Norman CENTRAL INDEX KEY: 0000898544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 22923478 MAIL ADDRESS: STREET 1: 800 N. GLEBE ROAD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER NAME: FORMER CONFORMED NAME: PAYSON NORMAN C MD DATE OF NAME CHANGE: 19930310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 form4-05132022_010509.xml X0306 4 2022-05-11 0001551306 Progyny, Inc. PGNY 0000898544 Payson Norman C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 true false false false Common Stock 2022-05-11 4 S 0 5518 33.30 D 491928 I See footnote Common Stock 2022-05-11 4 S 0 1100 34.18 D 490828 I See footnote Common Stock 2022-05-12 4 S 0 5305 33.13 D 485523 I See footnote Common Stock 2022-05-12 4 S 0 1313 33.89 D 484210 I See footnote Common Stock 122493 I See footnote Common Stock 8652 D Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.925 to $33.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.93 to $34.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 to $33.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.585 to $34.42, inclusive. The Reporting P erson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities. /s/ Jennifer Bealer, Attorney-in-Fact 2022-05-13